|
1
|
Howlader N, Noone AM, Krapcho M, Miller D,
Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et
al: SEER Cancer Statistics Review, 1975–2013. November. 2015,
National Cancer Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2013/based
on SEER data submission, posted to the SEER web site. April
25–2016
|
|
2
|
Worden FP and Kalemkerian GP: Therapeutic
advances in small cell lung cancer. Expert Opin Investig Drugs.
9:565–579. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalemkerian GP: Advances in
pharmacotherapy of small cell lung cancer. Expert Opin
Pharmacother. 15:2385–2396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Darnell RB and Posner JB: Paraneoplastic
syndromes involving the nervous system. N Engl J Med.
349:1543–1554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanaji N, Watanabe N, Kita N, Bandoh S,
Tadokoro A, Ishii T, Dobashi H and Matsunaga T: Paraneoplastic
syndromes associated with lung cancer. World J Clin Oncol.
5:197–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dalmau J, Graus F, Rosenblum MK and Posner
JB: Anti-Hu-associated paraneoplastic encephalomyelitis/sensory
neuronopathy. A clinical study of 71 patients. Medicine
(Baltimore). 71:59–72. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mawhinney E, Gray OM, McVerry F and
McDonnell GV: Paraneoplastic sensorimotor neuropathy associated
with regression of small cell lung carcinoma. BMJ Case Reports.
2010:pii: bcr0120091486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roberts WK, Deluca IJ, Thomas A, Fak J,
Williams T, Buckley N, Dousmanis AG, Posner JB and Darnell RB:
Patients with lung cancer and paraneoplastic Hu syndrome harbour
HuD-specific type 2 CD8+ T cells. J Clin Invest. 119:2042–2051.
2009.PubMed/NCBI
|
|
9
|
Gozzard P and Maddison P: Which antibody
and which cancer in which paraneoplastic syndromes? Pract Neurol.
10:260–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pignolet BS, Gebauer CM and Liblau RS:
Immunopathogenesis of paraneoplastic neurological syndromes
associated with anti-Hu antibodies: A beneficial antitumor immune
response going awry. Oncoimmunology. 2:e273842013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bruno MK, Winterkorn JM, Edgar MA, Kamal A
and Stübgen JP: Unilateral Adie pupil as sole ophthalmic sign of
anti-Hu paraneoplastic syndrome. J Neuroophthalmol. 20:248–249.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harriman DG and Garland H: The pathology
of Adie's syndrome. Brain. 91:401–418. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hersh B, Dalmau J, Dangond F, Gultekin S,
Geller E and Wen PY: Paraneoplastic opsoclonus-myoclonus associated
with anti-Hu antibody. Neurology. 44:1754–1755. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin L, Qu H and Chen Q: Proliferative
response of peripheral blood mononuclear cells in anti-Hu
antibody-associated patients with paraneoplastic neurological
syndrome and their depressant effect on small cell lung cancer
cells. Mol Med Rep. 11:1595–1600. 2015.PubMed/NCBI
|
|
15
|
Graus F, Dalmou J, Reñé R, Tora M, Malats
N, Verschuuren JJ, Cardenal F, Viñolas N, del Muro J Garcia, Vadell
C, et al: Anti-Hu antibodies in patients with small-cell lung
cancer: Association with complete response to therapy and improved
survival. J Clin Oncol. 15:2866–2872. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Douglas CA and Ellershaw J: Anti-Hu
antibodies may indicate a positive response to chemotherapy in
paraneoplastic syndrome secondary to small cell lung cancer.
Palliat Med. 17:638–639. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kazarian M, Calbo J, Proost N, Carpenter
CL, Berns A and Laird-Offringa IA: Immune response in lung cancer
mouse model mimics human anti-Hu reactivity. J Neuroimmunol.
217:38–45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dalmau J, Graus F, Cheung NK, Rosenblum
MK, Ho A, Cañete A, Delattre JY, Thompson SJ and Posner JB: Major
histocompatibility proteins, anti-Hu antibodies and paraneoplastic
encephalomyelitis in neuroblastoma and small cell lung cancer.
Cancer. 75:99–109. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smitt P Sillevis, Grefkens J, de Leeuw B,
van den Bent M, van Putten W, Hooijkaas H and Vecht C: Survival and
outcome in 73 anti-Hu positive patients with paraneoplastic
encephalomyelitis/sensory neuronopathy. J Neurol. 249:745–753.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aguirre-Cruz L, Charuel JL, Carpentier AF,
Benyahia B, Delattre JY and Musset L: Clinical relevance of
non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo
paraneoplastic diseases. J Neurooncol. 71:39–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maddison P and Lang B: Paraneoplastic
neurological autoimmunity and survival in small-cell lung cancer. J
Neuroimmunol. 201–202. 159–162. 2008.
|
|
22
|
Tsou JA, Kazarian M, Patel A, Galler JS,
Laird-Offringa IA, Carpenter CL and London SJ: Low level anti-Hu
reactivity: A risk marker for small cell lung cancer? Cancer Detect
Prev. 32:292–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gill S, Murray N, Dalmau J and Thiessen B:
Paraneoplastic sensory neuronopathy and spontaneous regression of
small cell lung cancer. Can J Neurol Sci. 30:269–271. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pujol JL, Godard AL, Jacot W and Labauge
P: Spontaneous complete remission of a non-small cell lung cancer
associated with anti-Hu antibody syndrome. J Thorac Oncol.
2:168–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kazarian M and Laird-Offringa IA:
Small-cell lung cancer-associated autoantibodies: Potential
applications to cancer diagnosis, early detection, and therapy. Mol
Cancer. 10:332011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Voltz RD, Posner JB, Dalmau J and Graus F:
Paraneoplastic encephalomyelitis: An update of the effects of the
anti-Hu immune response on the nervous system and tumour. J Neurol
Neurosurg Psychiatry. 63:133–136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Graus F, Keime-Guibert F, Reñe R, Benyahia
B, Ribalta T, Ascaso C, Escaramis G and Delattre JY:
Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of
200 patients. Brain. 124:1138–1148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
List M, Jamous F, Gupta A and Huntington
M: Anti-Hu positive antibodies and small cell carcinoma: A single
center review. S D Med. 68:251–255. 2015.PubMed/NCBI
|
|
29
|
Keime-Guibert F, Graus F, Fleury A, René
R, Honnorat J, Broet P and Delattre JA: Treatment of paraneoplastic
neurological syndromes with antineuronal antibodies (Anti-Hu,
Anti-Yo) with a combination of immunoglobulins, cyclophosphamide
and methylprednisolone. J Neurol Neurosurg Psychiatry. 68:479–482.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Greenlee JE, Clawson SA, Hill KE, Wood B,
Clardy SL, Tsunoda I, Jaskowski TD and Carlson NG: Neuronal uptake
of anti-Hu antibody, but not anti-Ri antibody, leads to cell death
in brain slice cultures. J Neuroinflammation. 11:1602014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roberts WK, Deluca IJ, Thomas A, Fak J,
Williams T, Buckley N, Dousmanis AG, Posner JB and Darnell RB:
Patients with lung cancer and paraneoplastic Hu syndrome harbor
HuD-specific type 2 CD8+T cells. J Clin Invest. 119:2042–2051.
2009.PubMed/NCBI
|
|
32
|
Antoine JC: Peripheral neuropathies
associated with antibodies directed to intracellular neural
antigens. Rev Neurol (Paris). 170:570–576. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pignolet BS, Gebauer CM and Liblau RS:
Immunopathogenesis of paraneoplastic neurological syndromes
associated with anti-Hu antibodies: A beneficial antitumor immune
response going awry. Oncoimmunology. 2:e273842013. View Article : Google Scholar : PubMed/NCBI
|
